EMGT treatment reduced progression risk in half, demonstrating the value of IOP lowering in early glaucoma. Age and indicators of disease severity also predicted progression.
Setting/Participants: Two hundred fifty-five openangle glaucoma patients randomized to argon laser trabeculoplasty plus topical betaxolol or no immediate treatment (129 treated; 126 controls) and followed up every 3 months. Methods: Progression was determined by perimetric and photographic optic disc criteria. Patient-based risk of progression was evaluated using Cox proportional hazard regression models and was expressed as hazard ratios (HR) with 95% confidence intervals (95% CI). Results: After 6 years, 53% of patients progressed. In multivariate analyses, progression risk was halved by treatment (HR = 0.50; 95% CI, 0.35-0.71). Predictive baseline factors were higher intraocular pressure (IOP) (ie, the higher the baseline IOP, the higher the risk), exfoliation, and having both eyes eligible (each of the latter 2 factors doubled the risk), as well as worse mean deviation and older age. Progression risk decreased by about 10% with each millimeter of mercury of IOP reduction from baseline to the first follow-up visit (HR=0.90 per millimeter of mercury decrease; 95% CI, 0.86-0.94). The first IOP at that visit (3 months' follow-up) was also related to progression (HR = 1.11 per millimeter of mercury higher; 95% CI, 1.06-1.17), as was the mean IOP at follow-up (HR=1.13 per millimeter of mercury higher; 95% CI, 1.07-1.19). The percent of patient follow-up visits with disc hemorrhages was also related to progression (HR=1.02 per percent higher; 95% CI, 1.01-1.03). No other factors were identified. Conclusions: Patients treated in the EMGT had half of the progression risk of control patients. The magnitude of initial IOP reduction was a major factor influencing outcome. Progression was also increased with higher baseline IOP, exfoliation, bilateral disease, worse mean deviation, and older age, as well as frequent disc hemorrhages during follow-up. Each higher (or lower) millimeter of mercury of IOP on follow-up was associated with an approximate 10% increased (or decreased) risk of progression.
Purpose
In this study, the authors investigated factors that affect bilingual children’s vocabulary and story recall abilities in their 2 languages.
Method
Participants included 191 Latino families and their children, who averaged 59 months of age. Data on parental characteristics and children’s exposure to and usage of Spanish and English were collected. The authors assessed children’s Spanish and English vocabulary and story recall abilities using subtests of the Woodcock–Muñoz Language Survey—Revised (Woodcock, Muñoz-Sandoval, Ruef, & Alvarado, 2005).
Results
Sizeable percentages of variation in children’s English (R2 = .61) and Spanish (R2 = .55) vocabulary scores were explained by children’s exposure to, and usage of, each language and maternal characteristics. Similarly, variations in children’s story recall scores in English (R2 = .38) and Spanish (R2 = .19) were also explained by the factors considered in this investigation. However, the authors found that different sets of factors in each category affected children’s vocabulary and story recall abilities in each language.
Conclusions
Children’s exposure to and usage of their two languages as well as maternal characteristics play significant roles in bilingual individuals’ language development. The results highlight the importance of gathering detailed sociolinguistic information about bilingual children when these children are involved in research and when they enter the educational system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations –citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.